新抗原瘤疫苗接种取决于由腺相关病毒等粒子传递的CD4许可
Lasse Neukirch1, Silke Uhrig-Schmidt1, Katharina von Werthern1
1Clinical Cooperation Unit "Applied Tumor Immunity", German Cancer Research Center (DKFZ), Im Neuenheimer Feld 460, Heidelberg, Germany.
概括
这项研究开发了一种基于腺相关病毒 (AAV) 的病毒样粒子 (VLP) 疫苗,用于个性化癌症治疗. 该疫苗有效地向新抗原,增强CD8+T细胞的反应,这对于瘤根除至关重要.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 疫苗开发 疫苗开发
背景情况:
- 由于基因组测序成本降低和疫苗技术改进,个性化癌症治疗正在取得进展.
- 针对由个体突变产生的癌症新抗原,是开发有效瘤疗法的关键策略.
- 基于腺相关病毒 (AAV) 的病毒样颗粒 (VLPs) 为疫苗制造提供了一个新的平台.
研究的目的:
- 使用AAV-VLP平台开发和评估一种新抗原特异蛋白疫苗.
- 研究由AAV囊介导的CD4+T细胞反应在癌症治疗中的作用.
- 通过评估相关的MHCII类辅助的必要性来优化类疫苗的组成.
主要方法:
- 使用AAV-VLP平台构建一种新抗原特定蛋白质疫苗.
- 在癌症预防和治疗的小鼠模型中评估疫苗的疗效.
- 从AAV囊中脱离主要基因相容性复合体 (MHC) 的II类辅助,以制备优化的疫苗.
主要成果:
- 基于AV-VLP的新抗原疫苗在临床前的小鼠模型中显示出有效性.
- 由AAV囊体影响的CD4+T细胞反应被发现是成功治疗小鼠黑色素瘤的关键.
- 一种优化的疫苗配方,独立于瘤特异性CD4+T细胞反应,被证明是有效的,突出显示MHCII类表位对CD8+T细胞活性的重要性.
结论:
- AAV-VLP代表了开发用于个性化癌症治疗的新表位疫苗的有希望的平台.
- 这项研究强调了MHCII类表位在产生强大的CD8+T细胞介导的抗瘤免疫力方面的关键作用.
- 这些发现支持基于AAVLP的新表位素疫苗在治疗癌症患者的潜在临床应用.
更多相关视频
相关概念视频
01:30Cancer Vaccines
517
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
517
01:27Tumor Immunotherapy
664
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
664
01:51Vaccinations
45.3K
Overview
45.3K
01:26Antigens Involved in Adaptive Immunity
690
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
690
01:29Immune Response Against Viral Pathogens
929
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
929